Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform

November 21, 2014 6:33 AM UTC
Get Alerts ACAD Hot Sheet
Price: $22.16 -1.07%

Rating Summary:
    16 Buy, 11 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

Cowen initiated coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with an Outperform rating and a price target of $46.00.

For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.

Shares of Acadia Pharmaceuticals closed at $27.74 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Cowen & Co